SC

Stewart Craig

Chief Technology Officer

Optieum Biotechnologies

Therapeutic Areas

Optieum Biotechnologies Pipeline

DrugIndicationPhase
PROGRAM-1solid tumor, cancer associated fibroblastPre-Clinical
PROGRAM-2hematological malignancies, autoimmune disordersPre-Clinical
PROGRAM-3UndisclosedDiscovery